Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-04 Purchase | 2024-12-06 4:05 pm | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 25,975 | $3.85 | $100,004 | 25,975 (Indirect) | View |
| 2024-12-04 Purchase | 2024-12-04 5:20 pm | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 8,000 | $3.7665 | $30,132 | 55,257 (Indirect Direct) | View |
| 2024-11-25 Purchase | 2024-11-27 07:05 am | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 6,266 | $3.6408 | $22,814 | 433,721 (Indirect Direct) | View |
| 2024-11-25 Purchase | 2024-11-27 07:00 am | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 12,829 | $3.8175 | $48,974 | 48,800 (Direct) | View |
| 2024-11-25 Purchase | 2024-11-26 07:00 am | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 26,500 | $3.7912 | $100,468 | 228,672 (Indirect Direct) | View |
| 2024-06-17 Purchase | 2024-06-18 07:48 am | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 1,800 | $9.815 | $17,667 | 35,971 (Direct) | View |
| 2024-06-14 Purchase | 2024-06-18 07:45 am | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 4,587 | $10.9 | $49,990 | 164,792 (Indirect Direct) | View |
| 2024-06-13 Purchase | 2024-06-13 5:19 pm | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 100,000 | $1.1743 | $117,430 | 207,572 (Indirect Direct) | View |
| 2024-06-03 Purchase | 2024-06-04 4:02 pm | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 34,246 | $1.4598 | $49,992 | 1,553,984 (Indirect) | View |
| 2024-05-31 Purchase | 2024-06-03 4:05 pm | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 25,006 | $1.3999 | $35,007 | 341,716 (Direct) | View |
| 2024-05-31 Purchase | 2024-06-03 4:01 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 55,000 | $1.38 | $75,900 | 427,455 (Indirect Direct) | View |
| 2024-05-29 Purchase | 2024-05-30 4:05 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 30,031 | $1.3324 | $40,014 | 372,455 (Indirect Direct) | View |
| 2024-03-06 Purchase | 2024-03-08 11:24 am | Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner | 60,431,039 | $0.95 | $57,409,487 | 116,773,394 (Direct) | View |
| 2024-01-30 Purchase | 2024-02-01 4:53 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 127,206 | $0.7131 | $90,710 | 342,424 (Indirect Direct) | View |
| 2024-01-26 Purchase | 2024-01-30 4:57 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 135,879 | $0.57753 | $78,474 | 215,218 (Indirect Direct) | View |
| 2024-01-24 Purchase | 2024-01-26 5:40 pm | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 280,000 | $0.4996 | $139,888 | 1,375,425 (Direct) | View |
| 2024-01-24 Purchase | 2024-01-26 5:38 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 51,996 | $0.49 | $25,478 | 79,339 (Indirect Direct) | View |
| 2023-12-21 Purchase | 2023-12-26 5:00 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 3,663 | $0.3283 | $1,203 | 27,343 (Indirect Direct) | View |
| 2023-12-18 Purchase | 2023-12-19 7:11 pm | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 125,000 | $0.2587 | $32,338 | 316,710 (Direct) | View |
| 2023-12-18 Purchase | 2023-12-19 7:10 pm | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 23,680 | $0.29466 | $6,978 | 23,680 (Direct) | View |
| 2023-12-15 Purchase | 2023-12-19 7:09 pm | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 595,425 | $0.31698 | $188,737 | 1,095,425 (Direct) | View |
| 2023-12-14 Purchase | 2023-12-18 4:16 pm | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 185,200 | $0.26992 | $49,989 | 1,567,814 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-17 Option Award | 2024-07-19 07:36 am | N/A 2034-07-17 | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 34,500 | $0 | 34,500 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:19 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:15 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Morich Frank Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:13 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Woods Lori A Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:11 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | HENSON HEIDI Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:09 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:07 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:05 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-04-23 Exercise | 2024-04-24 4:35 pm | N/A N/A | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 30,000 | $0.36 | 204,030 (Direct) | View |
| 2024-04-23 Exercise | 2024-04-24 4:35 pm | N/A 2032-08-09 | Perspective Therapeutics Inc. | CATX | Austin Mark John VP Finance/Prin Fin&Acct Offic | 30,000 | $0 | 204,030 (Direct) | View |
Ownership | 2024-02-01 07:56 am | N/A N/A | Perspective Therapeutics Inc. | CATX | Lantheus Alpha Therapy LLC Lantheus Holdings Inc. 10% Owner | 0 | $0 | 56,342,355 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:44 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 1,477,619 | $0 | 2,885,688 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:42 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Spoor Johan M. CEO | 3,338,878 | $0 | 11,793,635 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:36 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Hunt Jonathan Robert Chief Financial Officer | 1,248,776 | $0 | 2,527,429 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:34 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Morich Frank Director | 230,000 | $0 | 2,037,471 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:32 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Williamson Robert F III Director | 230,000 | $0 | 930,000 (Direct) | View |